Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,316 across all filing types
Latest filing 2025-05-17 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter from Dr. Reddy's Laboratories informing stock exchanges about the completion of a USFDA GMP inspection and the issuance of a Form 483 with observations. It is a regulatory disclosure under SEBI regulations, providing information about a regulatory inspection event. The document does not contain financial data, audit results, or detailed report content. It is a brief announcement for regulatory compliance and record-keeping purposes. The document length is only 1274 characters, indicating it is not a full report but a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-17 English
6-K Filing
Regulatory Filings
2025-05-16 English
Transcript of earnings call conducted on May 9, 2025
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on May 9, 2025, discussing the financial results for the quarter and full fiscal year ended March 31, 2025. It includes comprehensive financial data such as revenue, EBITDA, profit before tax, earnings per share, cash flows, and business highlights. The presence of a Q&A session and the detailed financial and operational commentary are characteristic of an earnings call transcript. The document explicitly states it is a transcript of the earnings call and includes management discussion and Q&A. Therefore, the appropriate classification is Call Transcript (CT). The document length (15,000 characters) and content confirm it is the full transcript, not just an announcement or summary.
2025-05-15 English
FORM 6-K
Regulatory Filings
2025-05-14 English
Schedule of Analyst / Institutional Investor meetings
Regulatory Filings Classification · 95% confidence The document is a letter from Dr. Reddy's Laboratories Ltd. addressed to stock exchanges, informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is purely an announcement of scheduled investor meetings and does not contain any financial data, report, or detailed presentation. The document length is short (1626 characters), and it serves as an informational notice rather than a report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it only announces the schedule and does not contain the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-05-14 English
FORM 6-K
Regulatory Filings
2025-05-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.